Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Sadif Analytics (Premium)
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cytrx Corp announces pricing of about $75 mln public offering of common stock

Friday, 31 Jan 2014 09:00am EST 

Cytrx Corp:Says the pricing of its previously announced underwritten public offering of 11.5 mln shares of common stock at a public offering price of $6.50 per share for gross proceeds of about $75 mln.Says it intends to use the net proceeds of the offering to fund clinical trials of its drug candidate aldoxorubicin and for general corporate purposes, which may include working capital, capital expenditures, research and development and other commercial expenditures.Says Jefferies LLC is the sole book-running manager for the offering. Oppenheimer & Co. Inc., Aegis Capital Corp. and H.C. Wainwright & Co., LLC are acting as co-lead managers for the offering. 

Company Quote

0.03 +0.90%
28 Aug 2014